Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

XNYS:DNA 4:00:00 PM EDT

12.79

-0.20 (-1.54%)

: $12.45 -0.34 (-2.66%)

Market Cap (Intraday)	718.79M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$38.95 Million
Adjusted EPS	-$1.24

See more estimates

10-Day MA	$12.93
50-Day MA	$12.74
200-Day MA	$10.46

See more pivots

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A Stock, XNYS:DNA

27 Drydock Avenue, 8th floor, Boston, Massachusetts 02210

United States of America

Phone: +1.877.422.5362

Number of Employees: 834

http://www.ginkgobioworks.com

Description

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. It operates through the Cell Programming/Foundry, and Biosecurity segments. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.